Journal article
Novel Loci for Metabolic Networks and Multi-Tissue Expression Studies Reveal Genes for Atherosclerosis
Michael Inouye, Samuli Ripatti, Johannes Kettunen, Leo-Pekka Lyytikainen, Niku Oksala, Pirkka-Pekka Laurila, Antti J Kangas, Pasi Soininen, Markku J Savolainen, Jorma Viikari, Mika Kahonen, Markus Perola, Veikko Salomaa, Olli Raitakari, Terho Lehtimaki, Marja-Riitta Taskinen, Marjo-Riitta Jaervelin, Mika Ala-Korpela, Aarno Palotie, Paul IW de Bakker
PLoS Genetics | PUBLIC LIBRARY SCIENCE | Published : 2012
Related Projects (1)
Grants
Awarded by NHMRC Biomedical Postdoctoral Fellowship
Awarded by Victorian Life Sciences Computing Initiative
Awarded by Academy of Finland Center of Excellence in Complex Disease Genetics
Awarded by Academy of Finland
Awarded by Wellcome Trust, UK
Awarded by Responding to Public Health Challenges Research Programme of the Academy of Finland
Awarded by Tampere University Hospital
Awarded by European Union
Awarded by Medical Research Council
Funding Acknowledgements
MI was supported by an NHMRC Biomedical Postdoctoral Fellowship (no. 637400). The analyses in this study were supported by project VR0126 of the Victorian Life Sciences Computing Initiative. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), the Academy of Finland (251217), the Finnish Foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The study was supported with funds from the Wellcome Trust, UK (project grant GR069224). The Young Finns Study has been financially supported by the Academy of Finland [grants 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi)]; the Social Insurance Institution of Finland; Kuopio, Tampere, and Turku University Hospital Medical Funds; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research and Finnish Cultural Foundation; Tampere Tuberculosis Foundation (TL, MK); and The Emil Aaltonen Foundation (TL). The metabolomics work was supported by grants from the Academy of Finland (grant 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant 129269 to MJS and 129429 to MA-K), the Finnish Foundation for Cardiovascular Research (MJS, MA-K), the Jenny and Antti Wihuri Foundation (AJK), and the Strategic Research Funding from the University of Oulu. The DILGOM-study was supported by the Academy of Finland, grant 118065. VS was supported by grants 139635 and 129494 from the Academy of Finland. The Tampere Vascular Study was supported with grants from the Competitive Research Funding of the Tampere University Hospital (Grant 9M048 and 9N035 for TL), the Emil Aaltonen Foundation (TL), the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Research Foundation of Orion Corporation, the Jenny and Antti Wihuri Foundation, and the Academy of Finland (Grant no. 104821), the Finnish Foundation for Cardiovascular Research, the Yrjo Jahnsson Foundation, and European Union 7th Framework Program (grant 201668, AtheroRemo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.